Versant Diagnostics announced a $100 million funded strategy to expand services to medical providers earlier in the year. The strategy includes purchasing pathology groups and converting them to digital, while maintaining the original physician leadership of the acquired practices.
Financial terms of the acquisitions were not disclosed.
